Modulators of cystic fibrosis transmembrane conductance regulator

Details for Australian Patent Application No. 2008298545 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Hadida Ruah, Sara S.; Zhou, Jinglan; Binch, Hayley; Hazlewood, Anna; Fanning, Lev T.D.; Grootenhuis, Peter D.J.

Agent Baldwins

Pub. Number AU-A-2008298545

PCT Pub. Number WO2009/036412

Priority 60/972,599 14.09.07 US

Filing date 15 September 2008

Wipo publication date 19 March 2009

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/036412 Priority application(s): WO2009/036412

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008298551-Apparatuses, systems, and methods for low-coherence interferometry (LCI)

2008298533-Methods and systems for generating desktop environments providing integrated access to remote and local resources